← Back
$ALLO All transactions

Allogene Therapeutics, Inc.

M

$ Value

$0

Shares

47,700

Price

$0

Filed

Dec 22

Insider

Name

Kazam Joshua A

Title

CIK

0001221355

Roles

Director

Transaction Details

Transaction Date

2025-12-18

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

350,763

Footnotes

On June 23, 2025, this grant was erroneously reported as 94,500 shares and is corrected here upon the vesting of the first of the semi-annual installments. | Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2018 Plan. | Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date.

Filing Info

Accession No.

0001221355-25-000005

Form Type

4

Issuer CIK

0001737287

Kazam Joshua A's History

Date Ticker Type Value
2025-12-18 ALLO M $0
2025-12-18 ALLO M $0
2025-06-20 KRON U $54K
2025-06-20 KRON D $0
2025-06-20 KRON D $0
2025-06-20 KRON D $0
2025-06-20 KRON D $0
2025-06-18 ALLO A $0

Other Insiders at ALLO (90d)

Insider Bought Sold Last
Yoshiyama Annie
SVP, Finance
$22K 2026-04-21
Beneski Benjamin Machinas
SVP, Chief Technical Officer
$7K 2026-03-31